首页> 外文期刊>Thoracic cancer. >MicroRNA ‐374b mediates the initiation of non‐small cell lung cancer by regulating ITGB1 and p53 expressions
【24h】

MicroRNA ‐374b mediates the initiation of non‐small cell lung cancer by regulating ITGB1 and p53 expressions

机译:MicroRNA -374B通过调节ITGB1和P53表达来介导非小细胞肺癌的启动

获取原文
           

摘要

BACKGROUND:Previous studies have shown that microRNAs (miRNAs) play important roles in the pathogenesis of human cancers. This study aims to clarify the role of miR-374b in non-small cell lung cancer (NSCLC).METHODS:In this study, RT-qPCR and western blot analysis were used to measure mRNA and protein expression. The regulatory mechanism of miR-374b/ITGB1 was investigated by dual-luciferase reporter, CCK-8, and transwell assays.RESULTS:MiR-374b expression was reduced in NSCLC tissues and associated with lymph node metastasis, tumor stage and prognosis in NSCLC patients. Functionally, overexpression of miR-374b inhibited cell viability and metastasis in NSCLC. In addition, miR-374b blocked EMT and promoted p53 expression in NSCLC. MiR-374b was found to directly target ITGB1. Furthermore, upregulation of ITGB1 weakened the antitumor effect of miR-374b in NSCLC.CONCLUSIONS:MiR-374b inhibits the tumorigenesis of NSCLC by downregulating ITGB1 and upregulating p53.? 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
机译:背景:以前的研究表明,MicroRNA(miRNA)在人类癌症发病机制中起重要作用。本研究旨在阐明miR-374b在非小细胞肺癌(NSCLC)中的作用。方法:在该研究中,使用RT-QPCR和Western印迹分析来测量mRNA和蛋白质表达。通过双荧光素酶报告,CCK-8和Transwell测定研究了MiR-374b / Itgb1的调节机制。结果:在NSCLC组织中,MiR-374b表达降低,并与NSCLC患者的淋巴结转移,肿瘤阶段和预后相关。在功能上,miR-374b的过表达抑制NSCLC中的细胞活力和转移。此外,miR-374b阻断EMT并促进了NSCLC中的P53表达。发现miR-374b直接针对ITGB1。此外,ITGB1的上调削弱了MiR-374b在Nsclc.Conclusions中的抗肿瘤效应:MiR-374b通过下调ITGB1并上调P53来抑制NSClc的肿瘤鉴定。? 2020作者。中国肺部肿瘤集团和约翰瓦里和儿子澳大利亚发表的胸癌

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号